1. Home
  2. SYF vs NTRA Comparison

SYF vs NTRA Comparison

Compare SYF & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYF
  • NTRA
  • Stock Information
  • Founded
  • SYF 1932
  • NTRA 2003
  • Country
  • SYF United States
  • NTRA United States
  • Employees
  • SYF N/A
  • NTRA N/A
  • Industry
  • SYF Finance: Consumer Services
  • NTRA Medical Specialities
  • Sector
  • SYF Finance
  • NTRA Health Care
  • Exchange
  • SYF Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • SYF 20.3B
  • NTRA 20.9B
  • IPO Year
  • SYF N/A
  • NTRA 2015
  • Fundamental
  • Price
  • SYF $55.45
  • NTRA $162.57
  • Analyst Decision
  • SYF Buy
  • NTRA Strong Buy
  • Analyst Count
  • SYF 21
  • NTRA 17
  • Target Price
  • SYF $62.00
  • NTRA $176.65
  • AVG Volume (30 Days)
  • SYF 4.4M
  • NTRA 1.1M
  • Earning Date
  • SYF 04-22-2025
  • NTRA 05-08-2025
  • Dividend Yield
  • SYF 2.16%
  • NTRA N/A
  • EPS Growth
  • SYF 4.77
  • NTRA N/A
  • EPS
  • SYF 7.27
  • NTRA N/A
  • Revenue
  • SYF $8,705,000,000.00
  • NTRA $1,696,911,000.00
  • Revenue This Year
  • SYF $94.67
  • NTRA $15.45
  • Revenue Next Year
  • SYF $8.22
  • NTRA $18.43
  • P/E Ratio
  • SYF $7.63
  • NTRA N/A
  • Revenue Growth
  • SYF 0.44
  • NTRA 56.75
  • 52 Week Low
  • SYF $40.55
  • NTRA $92.14
  • 52 Week High
  • SYF $70.93
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • SYF 61.71
  • NTRA 62.32
  • Support Level
  • SYF $52.99
  • NTRA $153.40
  • Resistance Level
  • SYF $54.81
  • NTRA $159.15
  • Average True Range (ATR)
  • SYF 1.72
  • NTRA 5.49
  • MACD
  • SYF 0.78
  • NTRA 1.30
  • Stochastic Oscillator
  • SYF 94.33
  • NTRA 94.64

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: